Press release
HIV Diagnostics Market to cross USD 5 bn by 2024| Top Players: Abbott Healthcare, Alere Inc, Apogee Flow Systems Ltd, BD Biosciences
HIV Diagnostics Market
Favorable regulatory landscape for HIV diagnostics will render positive impact on business growth. The U.S. FDA assesses performance and clinical value of blood screening and HIV diagnostic assays. It conducts regulatory study to create product standards and develop improved diagnostic methods to examine safety of biologics and drugs. FDA's multi-disciplinary research programs plays an important role in the development of test kits, vaccines, and therapeutic agents for use in AIDS and related conditions. Hence, government support coupled with favorable reimbursement scenario for HIV diagnostics will further accelerate HIV diagnostics market growth.
Request Sample Copy of this Report @ https://www.gminsights.com/request-sample/detail/491
Low-and middle-income Economies are the most potential yet underpenetrated avenue for the HIV diagnostics market players
As per UNAIDS, low-and middle-income countries have the highest ratio of people living with HIV. In 2017, 53% of the overall HIV-infected patient base were living in eastern and southern Africa, 16% in western and central Africa, 14% in Asia, and 6% in western and central Europe and North America. The statistics are a validation to the penetration scope of HIV diagnostics market participants in the low-and middle-income countries. These countries undoubtedly can be one of the most prominent recipients of the POC self-tests diagnostic approach, given a large pool of population in these countries burdened with either the unawareness of the epidemic or lack of treatment accessibility.
Simple amplification based assay - a blood diagnostic kit created by Cambridge university scientists received the “Popular Prize “at European Inventor award ceremony held on June 9, 2016 by European patent office. This kit can identify ailments like hepatitis B and HIV within less than 90 minutes by taking blood sample of the patient. The test cost only $17 and is same as pregnancy test where one stripe is positive and second is negative. This kit was used to test 40,000 persons for HIV in rural Africa. According to Helen Lee, who headed the team of Cambridge university researchers to develop the device, said that just a single drop of blood sample helps in detecting and treating the ailments in rural areas.
Thailand has become the first Asian nation to eradicate mother to child HIV transmission as per WHO reports achieving a greater milestone in its fight against the dreaded disease. Describing the eradication as an outstanding achievement, WHO said that Thailand was the first nation with large HIV endemic to assure an AIDS free population. This pronouncement is a boost for Thai health workers who have changed the country from one of the Asia’s most HIV ravaged communities to pin up the problem of efficiently handling the disease. According to WHO, routine screening tests conducted for HIV infected pregnant women along with free medication facilities in the country played a key role in preventing transmission of HIV virus from mother to child. The global HIV diagnostics market is segmented into key geographical regions including North America, Asia Pacific, Latin America, Europe and MEA.
Prominent industry players operating in the HIV diagnostics market include Siemens Healthineers, Merck, PointCare Technologies, Roche Diagnostics, Sysmex Partec, Qiagen, Cepheid, Hologic, ChemBio Diagnostics, Abbott, Alere, Apogee Flow Systems, BD Biosciences, Beckman Coulter Biomedical and Biomerieux. Key industry players majorly focus on several strategic initiatives including new product launch, partnership, merger and acquisitions to strengthen their market position and capitalize on market opportunities.
Make an inquiry for purchasing this report @ https://www.gminsights.com/inquiry-before-buying/491
Chapter 1. Methodology
1.1. Methodology
1.2. Market definitions
1.3. Forecast parameters
1.4. Data sources
1.4.1. Secondary
1.4.1.1. Paid sources
1.4.1.2. Unpaid sources
1.4.2. Primary
Chapter 2. Executive Summary
2.1. HIV diagnostics industry 3600 synopsis, 2013 - 2024
2.1.1. Business trends
2.1.2. Product trends
2.1.3. Regional trends
Chapter 3. HIV Diagnostics Industry Insights
3.1. Industry segmentation
3.2. Industry landscape, 2013 - 2024
3.3. Industry impact forces
Browse Full Report @ https://www.gminsights.com/industry-analysis/hiv-diagnostics-market
3.3.1. Growth drivers
3.3.1.1. Favorable regulatory landscape in the U.S.
3.3.1.2. Point-of-care (POC) HIV diagnostics development
3.3.1.3. Increasing number of blood transfusions and blood donations
3.3.1.4. Rising AIDS/HIV prevalence in low and middle-income countries
3.3.1.5. Increasing government initiatives for HIV awareness
Data Tables
TABLE 1 HIV diagnostics industry 360º synopsis, 2013 – 2024
TABLE 2 HIV diagnostics market, 2013-2017 (USD Million)
TABLE 3 HIV diagnostics market, 2018-2024 (USD Million)
TABLE 4 HIV diagnostics market, by product, 2013-2017 (USD Million)
TABLE 5 HIV diagnostics market, by product, 2018-2024 (USD Million)
TABLE 6 HIV diagnostics market, by region, 2013-2017 (USD Million)
TABLE 7 HIV diagnostics market, by region, 2018-2024 (USD Million)
Related Report- Dermal Filler Market By Type, By Application, By End-Use, Regional Outlook, Application Potential, Price Trends, Competitive Market Share & Forecast, 2018 – 2024
Know more@ https://www.marketwatch.com/press-release/at-66-cagr-dermal-filler-market-is-expected-to-exhibit-us-85-bn-by-2024-2019-05-06
Global Market Insights Inc. is a global market research and management consulting company catering to leading corporations, non-profit organizations, universities and government institutions. Our main goal is to assist and partner organizations to make lasting strategic improvements and realize growth targets. Our industry research reports are designed to provide granular quantitative information, combined with key industry insights, aimed at assisting sustainable organizational development.
Global Market Insights, Inc.
4 North Main Street
Selbyville, Delaware 19975 USA
Phone: 1-302-846-7766
Toll Free: 1-888-689-0688
Email:sales@gminsights.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release HIV Diagnostics Market to cross USD 5 bn by 2024| Top Players: Abbott Healthcare, Alere Inc, Apogee Flow Systems Ltd, BD Biosciences here
News-ID: 1728396 • Views: …
More Releases from Global Market Insights Inc.
Latest Research Report On Agricultural Adjuvants Market 2021. Major Players Incl …
The agricultural adjuvants market is expected to observe noteworthy growth on account of increasing demand for high-quality crops. Adjuvants commonly act as an additive in pesticides that increase its effectiveness and smoothen its mixing application.
The demand for plant protection products in countries like Bangladesh, India, and Vietnam has surged considerably in recent years. Ever-increasing population across developing economies has forced farmers to produce large quantities of high-quality yields. Citing…
U.S. Minoxidil Market 2021 Growth Opportunities and Competitive Landscape 2027 - …
The U.S. minoxidil industry has been impacted by the COVID-19 pandemic in the form of increased stress amid job losses and health issues, creating rising incidences of hair fall and associated problems. The industry is expected to gain commendable proceeds on account of an upsurge in research studies concerned with the effectiveness of minoxidil.
Citing one such instance, in January 2021, a study published in the Dermatologic Therapy supported the efficacy…
Global Sulfosuccinate Market 2021 Future Growth With Technology and Current Tren …
Owing to these factors, estimates have revealed that the global sulfosuccinate market size will exceed USD 475.7 million in annual estimation by 2024.
Increasing adoption of high-performance materials that meet application-specific requirements across various industries, including pharmaceuticals will stimulate the need for sulfosuccinate compounds. The surging disposable incomes of consumers mainly across the developing nations have also fueled their spending capacities on household and personal care.
Sulfosuccinates are mainly a mild type…
By 2026, Graphene Market will register over 35% CAGR | Applied Nanotech, Inc, an …
The global Graphene Market is slated to gain significant momentum over the forthcoming years, as a result of the growing product consumption in the electronics sector, particularly in developing countries. This high consumption can be attributed to its superior qualities such as high electrical conductivity, durability, and toughness.
Request a sample of this research report @
https://www.gminsights.com/request-sample/detail/233
Top Key Players in The Market are:
Graphenea S.A., Applied Graphene Materials plc, ACS…
More Releases for HIV
HIV-Associated Lipodystrophy Treatment Market - Increasing prevalence of HIV is …
HIV-associated lipodystrophy also known as lipodystrophy is a syndrome that occurs in HIV-infected patients. It is characterized by loss of subcutaneous fat from face, buttocks, arms and legs. Although the exact cause of HIV-associated lipodystrophy is not fully elucidated, some research evidence reported that it occurs in HIV-infected patients who are under antiretroviral medications. According to an article published in National Center for Biotechnology Information (NCBI) in 2014, prevalence of…
Global HIV Drugs Market | Global HIV Drugs Industry | Global HIV Drugs Market Re …
Human immunodeficiency Virus (HIV) could be a chronic and severe sickness which might be transferred from one person to a different through blood-to-blood and sexual contact. it's a deadly disease that attacks immune cells called CD-4 cells, creating body vulnerable to infections and alternative diseases. Over the years, the rising prevalence of HIV sickness worldwide has completely influenced the demand for HIV medicine. HIV medicine facilitate in preventing the multiplication…
HIV Therapeutics Market– South Africa's Aspen launches three-in-one HIV drug
Recent Developments
Aspen Pharma care, a South Africa’s drug maker has launched a triple combination of tablet for the treatment of HIV in the country where the HIV virus is the most prevalent. The company's new Emdolten drug is a once a day tablet which is in the form of dolutegravir, an antiretroviral medication that balances the drug’s resistance. The company has launched Aspen Stavudine which was its first generic ARV…
HIV Vaccine Market HIV Vaccine Clinical Pipeline Report 2022
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990
Report Table of Contents
Introduction to Human Immunodeficiency Virus (HIV) Vaccines
1.1 Overview
1.2 Antiquity of HIV Vaccine
Need for the Development of HIV Vaccine
Primer of HIV inside the Body
3.1 Inclusion of HIV Virus into the System
3.2 Interaction of HIV with Host
3.3 Eradication of HIV Virus
HIV Vaccine Development Process
4.1 Introduction
…
Global HIV Vaccine Market & HIV Vaccine Clinical Trial Outlook 2022
Worldwide, around the 35 Million of the people are currently infected with the HIV and about 30 Million of the people died because of the AIDS infection. There is no human example of clearing an HIV infection naturally. HIV virus makes copies of it very quickly, many types of HIV exist and new types of virus are continue to rise. Many scientists are still trying to understand the specific ways…
Hidden HIV Revealed: New Insights Into Latent HIV Infections
In spite of ever more effective therapies, HIV keeps managing to survive in the body. A comprehensive project conducted by the Austrian Science Fund FWF has clarified the molecular processes which contribute to this effect. In the process, approaches were discovered for possible therapies to combat the hidden reservoir formed by the virus.
Thanks to modern therapies, HIV infections have become controllable – but these treatments cannot provide a cure. Antiretroviral…
